InsiderClue
← All stocks

Perspective Therapeutics, Inc.

CATX Net selling
CIK 0000728387 #3362 in the set updated 17 Sep 2026
Bought (12 mo)
$42.24K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.62M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.62M
7 of 7 sales
Net
−$1.58M
−$1.58M against sales at will

By person

8 insiders · 9 transactions
0.2×

Johan (Thijs) Spoor holds only 0.2 times base salary in stock. $201.52K of shares against $680.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Johan (Thijs) Spoor last reported holding, valued at $3.15, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lantheus Alpha Therapy, LLC entity
10% owner
—
$1.27M (5)
−$1.27M
11,273,364
9.88%
$35.48M
−3.5%
Lantheus Holdings, Inc. entity
10% owner
—
$357.18K (2)
−$357.18K
11,563,425
10.13%
$36.39M
−1.0%
Hunt Jonathan Robert
Chief Accounting Officer
$22.29K (1)
—
+$22.29K
59,800
0.0524%
$188.20K
+66.2%
Williamson Robert F III
Director
$19.95K (1)
—
+$19.95K
118,846
0.1041%
$374.03K
+178.0%
Woods Lori A
Director
—
—
—
183,460
0.1607%
$577.39K
+14.7%
Spoor Johan M.
Chief Executive Officer
—
—
—
64,033
0.0561%
$201.52K
+2,141%
Graham Juan
Chief Financial Officer
—
—
—
35,354
0.0310%
$111.27K
+1,649%
HENSON HEIDI
Director
—
—
—
25,975
0.0228%
$81.75K
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Hunt Jonathan Robert
13 Nov 2025
Chief Accounting Officer
Buy
11,000
$2.03
$22.29K
Williamson Robert F III
12 Nov 2025
Director
Buy indirect
9,498
$2.10
$19.95K
Show all 9 transactions →

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Nov 2016